Cargando…

Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6

Gastric cancer is among the most common malignant tumors of the digestive tract. Establishing a robust and reliable animal model is the foundation for studying the pathogenesis of cancer. The present study established a mouse model of gastric carcinoma by inoculating immunocompetent mice with MKN45...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yanzhen, Wang, Quanyi, Yang, Yonghong, Wang, Quanquan, Zhang, Kai, Zhang, Xiaobei, Cho, William C., Shu, Zhenfeng, Li, Jiannan, Liu, Lili, Si, Chuanping, Hong, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165317/
https://www.ncbi.nlm.nih.gov/pubmed/32337226
http://dx.doi.org/10.1155/2020/1893434
_version_ 1783523451331411968
author Bi, Yanzhen
Wang, Quanyi
Yang, Yonghong
Wang, Quanquan
Zhang, Kai
Zhang, Xiaobei
Cho, William C.
Shu, Zhenfeng
Li, Jiannan
Liu, Lili
Si, Chuanping
Hong, Feng
author_facet Bi, Yanzhen
Wang, Quanyi
Yang, Yonghong
Wang, Quanquan
Zhang, Kai
Zhang, Xiaobei
Cho, William C.
Shu, Zhenfeng
Li, Jiannan
Liu, Lili
Si, Chuanping
Hong, Feng
author_sort Bi, Yanzhen
collection PubMed
description Gastric cancer is among the most common malignant tumors of the digestive tract. Establishing a robust and reliable animal model is the foundation for studying the pathogenesis of cancer. The present study established a mouse model of gastric carcinoma by inoculating immunocompetent mice with MKN45 cells using microcarrier. Sixty male C57BL/6 mice were randomly divided into three groups: a 2D group, an empty carrier group, and a 3D group, according to the coculture system of MKN45 and the microcarrier. The mouse models were established by hypodermic injection. Time to develop tumor, rate of tumor formation, and pathological features were observed in each group. In the 3D group, the tumorigenesis time was short, while the rate of tumor formation was high (75%). There was no detectable tumor formation in either the 2D or the empty carrier group. Both H&E and immunohistochemical staining of the tumor xenograft showed characteristic evidence of human gastric neoplasms. The present study successfully established a human gastric carcinoma model in immunocompetent mice, which provides a novel and valuable animal model for the cancer research and development of anticancer drugs.
format Online
Article
Text
id pubmed-7165317
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71653172020-04-24 Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6 Bi, Yanzhen Wang, Quanyi Yang, Yonghong Wang, Quanquan Zhang, Kai Zhang, Xiaobei Cho, William C. Shu, Zhenfeng Li, Jiannan Liu, Lili Si, Chuanping Hong, Feng Biomed Res Int Research Article Gastric cancer is among the most common malignant tumors of the digestive tract. Establishing a robust and reliable animal model is the foundation for studying the pathogenesis of cancer. The present study established a mouse model of gastric carcinoma by inoculating immunocompetent mice with MKN45 cells using microcarrier. Sixty male C57BL/6 mice were randomly divided into three groups: a 2D group, an empty carrier group, and a 3D group, according to the coculture system of MKN45 and the microcarrier. The mouse models were established by hypodermic injection. Time to develop tumor, rate of tumor formation, and pathological features were observed in each group. In the 3D group, the tumorigenesis time was short, while the rate of tumor formation was high (75%). There was no detectable tumor formation in either the 2D or the empty carrier group. Both H&E and immunohistochemical staining of the tumor xenograft showed characteristic evidence of human gastric neoplasms. The present study successfully established a human gastric carcinoma model in immunocompetent mice, which provides a novel and valuable animal model for the cancer research and development of anticancer drugs. Hindawi 2020-04-04 /pmc/articles/PMC7165317/ /pubmed/32337226 http://dx.doi.org/10.1155/2020/1893434 Text en Copyright © 2020 Yanzhen Bi et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bi, Yanzhen
Wang, Quanyi
Yang, Yonghong
Wang, Quanquan
Zhang, Kai
Zhang, Xiaobei
Cho, William C.
Shu, Zhenfeng
Li, Jiannan
Liu, Lili
Si, Chuanping
Hong, Feng
Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6
title Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6
title_full Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6
title_fullStr Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6
title_full_unstemmed Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6
title_short Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6
title_sort establishment of a human gastric cancer xenograft model in immunocompetent mice using the microcarrier-6
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165317/
https://www.ncbi.nlm.nih.gov/pubmed/32337226
http://dx.doi.org/10.1155/2020/1893434
work_keys_str_mv AT biyanzhen establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT wangquanyi establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT yangyonghong establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT wangquanquan establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT zhangkai establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT zhangxiaobei establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT chowilliamc establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT shuzhenfeng establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT lijiannan establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT liulili establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT sichuanping establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6
AT hongfeng establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6